Jan 23 (Reuters) - Novelion Therapeutics Inc NVLN.TO :
* Novelion Therapeutics announces acceptance of marketing authorization application for metreleptin by European Medicines Agency
* Novelion Therapeutics Inc - opinion from committee for medicinal products for human use is expected in December of 2017
* Novelion Therapeutics Inc- decision from committee for medicinal products for human use (CHMP) is expected in Q1 of 2018 Source text for Eikon: ID:nGNXNOARFa Further company coverage: NVLN.TO